falsefalse

Dr. Yarchoan on Unique Characteristics of Fibrolamellar Carcinoma

Mark Yarchoan, MD, discusses unique characteristics of fibrolamellar carcinoma.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Mark Yarchoan, MD, assistant professor of oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, discusses unique characteristics of fibrolamellar carcinoma (FC).

    FC is a distinct type of liver cancer, Yarchoan says. Unlike hepatocellular carcinoma (HCC), which typically occurs in older patients who have underlying liver disease like cirrhosis, FC tends to occur in younger patients without underlying liver disease.

    Additionally, the disease is characterized by the presence of DNAJB1-PRKACA oncogenic fusions or rearrangements, which are unique driver abnormalities for cancer growth, Yarchoan says. As such, FC is epidemiological and genetically distinct from HCC, Yarchoan concludes.


    x